Lenalidomide-induced acute acneiform folliculitis of the head and neck: Not only the anti-EGF receptor agents

Dermatology

Volumn 220, Issue 1, 2010, Pages 49-50

  Michot, Carine ^a   Guillot, Bernard ^a   Dereure, Olivier ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Acneiform rash; Folliculitis; Lenalidomide

Indexed keywords

BORTEZOMIB; DESONIDE; DEXAMETHASONE; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUCONAZOLE; LENALIDOMIDE;

AGED; CANDIDA ALBICANS; CASE REPORT; DRUG SUBSTITUTION; FEMALE; FOLLICULITIS; HEAD AND NECK DISEASE; HUMAN; LETTER; MICROBIOLOGICAL EXAMINATION; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PRIORITY JOURNAL; PUSTULE; RASH; REMISSION; SKIN BIOPSY;

ACNEIFORM ERUPTIONS; AGED; BORONIC ACIDS; CANDIDA ALBICANS; CANDIDIASIS; DESONIDE; DEXAMETHASONE; DOXYCYCLINE; FLUCONAZOLE; FOLLICULITIS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MULTIPLE MYELOMA; PYRAZINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; THALIDOMIDE;

EID: 76649083897     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258050     Document Type: Letter

References (6)

1. Rajkumar SV, Hayman SR, Lacy MQ, et al: Combination therapy with lenalidomide plus dexamethasone (REV/DEX) for newly diagnosed myeloma. Blood 2005; 106: 4050-4053.
2. Sviggum HP, Davis MDP, Rajkurmar SV, Dispenzieri A: Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma. Arch Dermatol 2006; 142: 1298-1302.
3. Hall VC, El-Azhary RA, Bouwhuis S, Rajkumar SV: Dermatologic side effects of thalidomide in patients with multiple myeloma. J Am Acad Dermatol 2003; 48: 548-552.
4. Noman AS, Koide N, Khuda II, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T: Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation. Biochem Biophys Res Commun 2008; 374: 683-687.
5. Gambillara E, Laffitte E, Widmer N, Decosterd LA, Duchosal MA, Kovacsovics T, Panizzon RG: Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia. Dermatology 2005; 211: 363-365.
6. Kunzle N, Venetz JP, Pascual M, Panizzon RG, Laffitte E: Sirolimusinduced acneiform eruption. Dermatology 2005; 211: 366-369.